Back to Search
ASHLEY FROST, MD
MD
Emergency Medicine Physician
NPI: 1669059044IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
U9917(TX)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
OTHER
Class of 2021
Research & Publications (20)
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.
PMID 18812445·Chest·2009
3-trial
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival.
PMID 18625676·Chest·2008
4-observational
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect.
PMID 15890561·Vascul Pharmacol·2005
3-trial
A review of the use of therapeutic communities with sexual offenders.
PMID 19666834·Int J Offender Ther Comp Criminol·2010
6-review
Minimal genomes, maximal productivity: comparative genomics of the photosystem and light-harvesting complexes in the marine cyanobacterium, Prochlorococcus.
PMID 19557544·Photosynth Res·2009
8-other
Learning to 'talk the talk: the relationship of psychopathic traits to deficits in empathy across childhood.
PMID 19445007·J Child Psychol Psychiatry·2009
8-other
Quality assurance ofallergen-specific immunotherapy during a national outbreak of anaphylaxis: results of a continuous sentinel event surveillance system.
PMID 19639720·J Investig Allergol Clin Immunol·2009
4-observational
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
PMID 19430405·Melanoma Res·2009
3-trial
A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.
PMID 19609101·Tumour Biol·2009
8-other
Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
PMID 19344510·Breast Cancer Res·2009
7-preclinical
Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts.
PMID 19308679·Cancer Microenviron·2009
8-other
Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1.
PMID 19221424·J Alzheimers Dis·2009
8-other
Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid.
PMID 19197145·Cancer Biol Ther·2009
7-preclinical
Serological screening for coeliac disease in adults with Turner's syndrome: prevalence and clinical significance of endomysium antibody positivity.
PMID 19208776·Eur J Endocrinol·2009
8-other
Interventional and surgical modalities of treatment in pulmonary hypertension.
PMID 19555860·J Am Coll Cardiol·2009
6-review
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
PMID 19002462·Cancer Chemother Pharmacol·2009
3-trial
Tenotomy versus tenodesis in the management of pathologic lesions of the tendon of the long head of the biceps brachii.
PMID 18762669·Am J Sports Med·2009
4-observational
Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors.
PMID 18955456·J Clin Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 UNIVERSITY BLVD
ROUND ROCK, TX 78665 - Phone
- (254) 724-2111
Quick Facts
- NPI
- 1669059044
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile